ADARx Pharmaceuticals, Inc. ADRX

Set alert

Price alert · ADRX

All alert types
16.19 USD +0.43 +2.73%

As of Nov 3, 10:54 AM ET

Bid
15.97 × 1
Ask
16.19 × 1
15.00 Day range 16.46
15.00 52-week range 23.21
YTD
-16.33%
1 year
-16.33%
Open
15.78
Prev close
15.76
Mkt cap
1.78B
Vol
82.99K
Avg vol
691.66K
EPS
-1.16
P/E
0.00
Div yield
0.00%
More statistics
Low
15.00
High
16.46
Forward P/E
-10.42
Beta
0.00
Short ratio
2.00
Inst. own
46.02%
Dividend
0.00
Ex-div date
50-d avg
18.21
200-d avg
18.21
1y target
34.25

1D chart

Chart tools
Interval

Signals (51)
NameTimeAgo
SMA: Bullish3:48 PM3 days ago
SMA: Bullish3:48 PM3 days ago
MACD: Buy Signal3:48 PM3 days ago
MACD: Sell Signal3:45 PM3 days ago
SMA: Bearish3:43 PM3 days ago
SMA: Bearish3:43 PM3 days ago
SMA: Bullish3:40 PM3 days ago
SMA: Bearish3:37 PM3 days ago
SMA: Bearish3:37 PM3 days ago
SMA: Bullish3:25 PM3 days ago
SMA: Bullish3:25 PM3 days ago
MACD: Buy Signal3:25 PM3 days ago
SMA: Bearish3:19 PM3 days ago
MACD: Sell Signal3:19 PM3 days ago
SMA: Bullish3:18 PM3 days ago
SMA: Bearish3:17 PM3 days ago
SMA: Bullish3:13 PM3 days ago
SMA: Bearish2:11 PM3 days ago
SMA: Bullish2:10 PM3 days ago
MACD: Buy Signal2:08 PM3 days ago

Newest 20 of 51.

Analyst view

Consensus: strong buy

Strong buy
Price target (mean) 34.25 +111.6% upside
Target (low)
32.00
Target (mean)
34.25
Target (high)
38.00
Ratings (0m) 5 5 buy · 0 hold · 0 sell
  • Strong buy2
  • Buy3
  • Hold0
  • Sell0
  • Strong sell0

Recommendation trend

  • This month 5

Earnings and revenue estimates

Consensus for the coming quarters and fiscal years

ADRX analyst estimates
PeriodEPS estimateLow – highYear agoEPS growthRevenue estimateRevenue growthAnalysts
Current quarter-0.36348-0.53 – -0.253670.000.0%2.58M0.0%3
Next quarter-0.37861-0.40 – -0.363630.000.0%2.58M0.0%3
Current year-1.68-1.89 – -1.550.000.0%5.94M0.0%3
Next year-1.51-1.81 – -1.18-1.68+9.9%39.87M+570.7%3

Upgrades and downgrades

The latest rating changes

ADRX analyst upgrades and downgrades
DateFirmActionFromTo
Oct 20, 2026TD CowenInitiated—Buy
Oct 20, 2026JP MorganInitiated—Overweight
Oct 20, 2026UBSInitiated—Buy
Oct 20, 2026Morgan StanleyInitiated—Overweight